VanEck Associates’s Insmed INSM Stock Holding History

VanEck Associates’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10.6M	Sell	99,048 -5,242	-5%	-$635K	0.01%	617
2026 Q1	$17.1M	Buy	104,290 +15,255	+17%	+$2.35M	0.01%	466
2025 Q4	$15.5M	Sell	89,035 -17,667	-17%	-$3.22M	0.01%	449
2025 Q3	$15.4M	Sell	106,702 -13,084	-11%	-$1.6M	0.01%	422
2025 Q2	$12.1M	Sell	119,786 -3,766	-3%	-$288K	0.01%	437
2025 Q1	$9.43M	Buy	123,552 +4,318	+4%	+$330K	0.01%	503
2024 Q4	$8.23M	Sell	119,234 -7,790	-6%	-$561K	0.01%	517
2024 Q3	$9.14M	Buy	+127,024	New	+$9.37M	0.01%	472

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

VanEck Associates's INSM Position: Q2 2026 in Review

VanEck Associates reduced its Insmed (INSM) stake by 5% in Q2 2026, selling an estimated $635K and leaving 99,048 shares worth $10.6M. The position accounts for 0.01% of the portfolio, ranked #617.

VanEck Associates first reported a position in INSM in Q3 2024 and has held it in 8 quarters since. The position peaked at $17.1M in Q1 2026. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

VanEck Associates held 99,048 shares of Insmed worth $10.6M as of Q2 2026.
VanEck Associates sold 5,242 Insmed shares in Q2 2026, an estimated $635K.
Insmed made up 0.01% of VanEck Associates's portfolio in Q2 2026, its #617 holding.
VanEck Associates first reported a position in Insmed in Q3 2024 and has held it in 8 quarters since.
VanEck Associates's Insmed position peaked at $17.1M in Q1 2026.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on VanEck Associates's 13F filing for Q2 2026, filed 14 Aug 2026.